MARK YOUR CALENDAR: “Advocating for Children and Adolescents on a National Level”

Thursday, December 3 at 7 PM CT
Zoom info to come.

Tamar Magarik Haro
Senior Director, Federal and State Advocacy at American Academy of Pediatrics

Tamar Magarik Haro has spent more than 16 years working in health care policy, public health, and advocacy where she has shaped and influenced many of the most consequential laws affecting the lives of millions of Americans, especially children. In Tamar’s role on the Senate Health, Education, Labor and Pensions (HELP) Committee, she played a key role in writing and negotiating the Patient Protection and Affordable Care Act with a particular focus on consumer protections, insurance market reforms, and public health. While on the HELP Committee, she also played a critical role in the development and passage of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, the PREEMIE Act, the Newborn Screening Saves Lives Act, the Ryan White HIV/AIDS Treatment Extension Act, among others. Both on and off Capitol Hill, Tamar is looked to for her knowledge of and strategic insights on Food and Drug Administration-related laws, regulations, and policies affecting children.

Currently a senior lobbyist at the American Academy of Pediatrics (AAP), where she oversees a team in DC and in Itasca, IL that includes federal and state advocacy staff, Tamar is a proven leader and seasoned advocate for pediatricians and children. She serves as principal advisor to AAP leadership and its 67,000 members on policy and advocacy related to immigrant child health, nutrition, mental health, and disaster preparedness and provides leadership on federal and state advocacy initiatives related to insurance coverage, Medicaid and CHIP, and Food and Drug Administration policy. Her tenacity and expertise on policy and legislative strategy resulted in the enactment and first-ever funding of pediatric tele-mental health grants totaling $50 million over 5 years. Tamar is a frequent public speaker to physician and non-physician audiences on advocacy and policy.

Leave a Reply

Your email address will not be published. Required fields are marked *